ECSP088938A - Procedimiento para preparar formulaciones secadas por aspersion de etravirina - Google Patents

Procedimiento para preparar formulaciones secadas por aspersion de etravirina

Info

Publication number
ECSP088938A
ECSP088938A EC2008008938A ECSP088938A ECSP088938A EC SP088938 A ECSP088938 A EC SP088938A EC 2008008938 A EC2008008938 A EC 2008008938A EC SP088938 A ECSP088938 A EC SP088938A EC SP088938 A ECSP088938 A EC SP088938A
Authority
EC
Ecuador
Prior art keywords
spray
etravirin
dryed
formulations
prepare
Prior art date
Application number
EC2008008938A
Other languages
English (en)
Inventor
Filip Rene Irene Kiekens
Jody Firmin Marceline Voorspoels
Lieven Elvire Colette Baert
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37179187&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP088938(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of ECSP088938A publication Critical patent/ECSP088938A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invención se refiere a un procedimiento para producir polvo secado por aspersión que comprende celulosa microcristalina en una dispersión sólida en un compuesto anti-VIH etravirina (TMC125) en un polímero soluble en agua.
EC2008008938A 2006-06-06 2008-12-03 Procedimiento para preparar formulaciones secadas por aspersion de etravirina ECSP088938A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06115029 2006-06-06

Publications (1)

Publication Number Publication Date
ECSP088938A true ECSP088938A (es) 2009-01-30

Family

ID=37179187

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008938A ECSP088938A (es) 2006-06-06 2008-12-03 Procedimiento para preparar formulaciones secadas por aspersion de etravirina

Country Status (26)

Country Link
US (2) US20090197903A1 (es)
EP (1) EP2029110B1 (es)
JP (1) JP5089685B2 (es)
KR (1) KR101179905B1 (es)
CN (1) CN101453989B (es)
AT (1) ATE522202T1 (es)
AU (1) AU2007255418C1 (es)
BR (1) BRPI0712346B8 (es)
CA (1) CA2651665C (es)
CY (1) CY1112154T1 (es)
DK (1) DK2029110T3 (es)
EC (1) ECSP088938A (es)
ES (1) ES2372983T3 (es)
HR (1) HRP20110883T1 (es)
IL (1) IL195710A (es)
ME (1) ME01305B (es)
MX (1) MX2008015686A (es)
NO (1) NO343652B1 (es)
NZ (1) NZ572702A (es)
PL (1) PL2029110T3 (es)
PT (1) PT2029110E (es)
RS (1) RS52053B (es)
RU (1) RU2406502C2 (es)
SI (1) SI2029110T1 (es)
WO (1) WO2007141308A1 (es)
ZA (1) ZA200810345B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008000746A1 (es) 2007-03-14 2008-09-22 Tibotec Pharm Ltd Composicion farmaceutica en solucion que comprende tmc278 y un polimero soluble en agua; proceso de preparacion de dicha composicion; y uso de un polvo que comprende tmc278 para tratar sida.
WO2009123169A1 (ja) * 2008-04-02 2009-10-08 アステラス製薬株式会社 アミド誘導体含有医薬組成物
EP2306980A2 (en) * 2008-06-30 2011-04-13 Tibotec Pharmaceuticals Powders for reconstitution
WO2013109354A2 (en) * 2011-12-07 2013-07-25 Texas Southern University Etravirine formulations and uses thereof
JP6301339B2 (ja) * 2012-09-27 2018-03-28 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 少なくとも１種の水溶性ビタミンｅ誘導体および少なくとも１種の親水性ポリマーを含む、保存において安定な無塵の均質な粒子製剤
CN112105680A (zh) * 2018-05-11 2020-12-18 株式会社三养社 固体分散体、其制备方法、使用其的扩链聚氨酯和包含其的环氧树脂组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2920956B2 (ja) * 1989-10-06 1999-07-19 藤沢薬品工業株式会社 ニルバジピン含有持続性錠剤
US6395303B1 (en) 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
JPH107558A (ja) * 1996-06-19 1998-01-13 Eisai Co Ltd 溶解性改善製剤
HRP20080359B1 (hr) * 1998-11-10 2016-01-01 Janssen Pharmaceutica N.V. PIRIMIDINI KOJI INHIBIRAJU REPLIKACIJU HIV-a
EP1027886B1 (en) * 1999-02-10 2008-07-09 Pfizer Products Inc. Pharmaceutical solid dispersions
CA2384188C (en) * 1999-09-24 2008-06-17 Janssen Pharmaceutica N.V. Antiviral compositions
DE19945982A1 (de) 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
US6531158B1 (en) * 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
PL371593A1 (en) * 2002-02-01 2005-06-27 Pfizer Products Inc. Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
AU2002350719A1 (en) * 2002-11-29 2004-06-23 Janssen Pharmaceutica N.V. Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
WO2004060352A1 (en) * 2002-12-19 2004-07-22 Pharmacia Corporation Non-hygroscopic formulation comprising a hydroscopic drug
WO2005011702A1 (en) * 2003-07-17 2005-02-10 Tibotec Pharmaceuticals Ltd. Process for preparing particles containing an antiviral
CA2547404A1 (en) * 2003-12-09 2005-06-23 Pfizer Inc. Compositions comprising an hiv protease inhibitor

Also Published As

Publication number Publication date
MX2008015686A (es) 2009-01-12
RU2008152411A (ru) 2010-07-20
US20090197903A1 (en) 2009-08-06
HK1129579A1 (en) 2009-12-04
HRP20110883T1 (hr) 2012-01-31
AU2007255418C1 (en) 2011-08-18
AU2007255418A1 (en) 2007-12-13
WO2007141308A1 (en) 2007-12-13
US9603803B2 (en) 2017-03-28
SI2029110T1 (sl) 2012-01-31
PL2029110T3 (pl) 2012-03-30
DK2029110T3 (da) 2011-12-19
IL195710A (en) 2014-02-27
CA2651665C (en) 2010-04-27
JP2009539804A (ja) 2009-11-19
KR101179905B1 (ko) 2012-09-07
NO20090061L (no) 2009-01-06
RU2406502C2 (ru) 2010-12-20
BRPI0712346B8 (pt) 2021-05-25
CN101453989A (zh) 2009-06-10
ZA200810345B (en) 2012-05-30
ATE522202T1 (de) 2011-09-15
EP2029110A1 (en) 2009-03-04
EP2029110B1 (en) 2011-08-31
CN101453989B (zh) 2012-06-13
ES2372983T3 (es) 2012-01-30
AU2007255418B2 (en) 2010-12-23
US20120208834A1 (en) 2012-08-16
NZ572702A (en) 2011-09-30
CA2651665A1 (en) 2007-12-13
CY1112154T1 (el) 2015-12-09
NO343652B1 (no) 2019-04-29
BRPI0712346B1 (pt) 2020-09-29
RS52053B (sr) 2012-04-30
ME01305B (me) 2012-04-30
KR20090024131A (ko) 2009-03-06
PT2029110E (pt) 2011-11-23
IL195710A0 (en) 2009-09-01
JP5089685B2 (ja) 2012-12-05
BRPI0712346A2 (pt) 2012-07-17

Similar Documents

Publication Publication Date Title
ECSP088938A (es) Procedimiento para preparar formulaciones secadas por aspersion de etravirina
WO2010149169A3 (en) Controlled release formulations
HK1223949A1 (zh) 稳定的可溶性预融合rsv f多肽
PH12013501241A1 (en) A water soluble composition comprising curcumin having enhanced bioavailability and process thereof
WO2009100995A3 (de) Lagerstabile produktsysteme für prämixformulierungen
WO2011049629A3 (en) Methods of making and using compositions comprising flavonoids
GEP20156328B (en) Solid pharmaceutical compositions and processes for their production
WO2008127646A8 (en) Transaminase-based processes for preparation of pregabalin
WO2008025015A8 (en) Epitope-protein scaffolds and their use
UA86731C2 (ru) Делимая галеновая форма модифицированного высвобождения активного ингредиента
MX2009002433A (es) Agente de control de pestes en la forma de suspension estable.
UA89394C2 (uk) Композиція оланзапіну або донепезилу, що розпадається при пероральному прийомі
PH12014502493A1 (en) Novel highly bioavailable, water soluble and sustained release nanoformulations of hydrophobic plant derived compounds and extracts
MX2010010057A (es) Proceso de fabricacion de dispersion acuosa estable de particulas finamente divididas, concentradas de biocida.
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
WO2009002538A3 (en) Amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib
WO2009094457A3 (en) Substituted benzhydrylethers
EP4309650A3 (en) Process for the preparation of tolerizing immune-modulating particles
WO2008111096A3 (en) Novel prodrugs
WO2008075205A3 (en) Improved process for the preparation of voriconazole
MX2010005323A (es) Composiciones de recubrimiento acuosas resistentes a las manchas.
WO2011127244A8 (en) ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECT
WO2009047634A3 (en) Aqueous formulations of acetaminophen for injection
WO2011009075A3 (en) Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
WO2010006697A3 (en) Powders for reconstitution